Aptose Biosciences (APTO) Prices 10.5M Share Common Offering at $5.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Aptose Announces Pricing of Public Offering of Common Shares
July 15, 2020 10:49 PM EDTSAN DIEGO and TORONTO, July 15, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose or the Company) (NASDAQ: APTO, TSX: APS), today announced that it priced its previously announced underwritten public offering of 10,500,000 common shares (the Offering) at a public offering price of US$5.25 per share. Gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by Aptose, are expected to be approximately US$55 million. The underwriters have been granted a 30-day option to purchase up to an additional 1,575,000 common shares in the Offering, under the same terms and conditions.Â
... More